Area of research
Oncology · Public Health, Environmental and Occupational Health
Research interest
Research focused on Cytokine release syndrome and Chimeric antigen receptor, with related work in CD22, CD19, Neurotoxicity. Notable publications include 'T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial', 'CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy', and 'Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events'.
Neurotoxicity following CD19/CD28ζ CAR T-cells in children and young adults with B-cell malignancies
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial